½ÃÀ庸°í¼­
»óǰÄÚµå
1684547

ü¿ÜÁø´Ü¿ë ÀǾàǰ(IVD) Æ÷Àå ½ÃÀå : ½ÃÀå ±âȸ, ¼ºÀå ÃËÁø¿äÀÎ, »ê¾÷ µ¿Ç⠺м®, ¿¹Ãø(2025-2034³â)

In-Vitro Diagnostics Packaging Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Global Market Insights Inc. | ÆäÀÌÁö Á¤º¸: ¿µ¹® 220 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°èÀÇ Ã¼¿ÜÁø´Ü¿ë ÀǾàǰ Æ÷Àå ½ÃÀåÀº 2024³â¿¡ 86¾ï ´Þ·¯ÀÇ Æò°¡¾×¿¡ À̸£·¶°í, 2025³âºÎÅÍ 2034³â±îÁö ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR) 5.1%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ÃßÁ¤µÇ°í ÀÖ½À´Ï´Ù.

½ÃÀåÀÇ ¼ºÀå ±Ëµµ´Â ¿©·¯ ¿äÀο¡ ÀÇÇØ °ßÀε˴ϴÙ. ÁÖ¿ä ÃËÁø¿äÀÎ Áß Çϳª´Â ½ÅÈï ½ÃÀå¿¡¼­ ÇöÁöÈ­µÈ Á¦Á¶ ¹× Æ÷Àå ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÏ´Â °ÍÀÔ´Ï´Ù. ÀÌ Áö¿ª¿¡¼­´Â ÇコÄɾî ÀÎÇÁ¶ó°¡ ±Þ¼ÓÈ÷ ¹ßÀüÇϰí ÀÖÀ¸¸ç, ±× °á°ú Áø´Ü °Ë»ç°¡ Áõ°¡Çϰí ÀÌ·¯ÇÑ °Ë»çÀÇ ¹«°á¼ºÀ» º¸ÀåÇÏ´Â ÆÐŰ¡ ¼Ö·ç¼ÇÀÌ ½Ã±ÞÇØÁö°í ÀÖ½À´Ï´Ù. ±× °á°ú, ½ÅÈï±¹ ½ÃÀå Æ¯À¯ÀÇ ¿ä±¸¿¡ ´ëÀÀÇÏ´Â Æ÷Àå Çõ½Å¿¡ ÁÖ·ÂÇÏ´Â ±â¾÷ÀÌ ´Ã°í ÀÖ½À´Ï´Ù. ¸ÂÃãÇü ÀÇ·á, Æ÷ÀÎÆ® ¿Àºê ÄÉ¾î °Ë»ç, ¼±Áø Áö¿ª¿¡¼­ÀÇ °í·ÉÈ­ µîÀÇ µ¿ÇâÀº °íǰÁúÀÇ IVD Æ÷Àå ¼ö¿ä¸¦ ÇÑÃþ ´õ ³ôÀÌ´Â ¿äÀÎÀÌ µÇ°í ÀÖ½À´Ï´Ù. ÀÌ ¼ºÀåÀº Áø´Ü °Ë»ç¿¡¼­ ¾ÈÀü¼º°ú Á¤È®¼ºÀÇ Á߿伺ÀÌ ´õ¿í ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ½À´Ï´Ù.

In-Vitro Diagnostics Packaging Market-IMG1

Á¦Ç° À¯Çüº°·Î º¼ ¶§ ½ÃÀåÀº Æ©ºê, º´ ¹× ¹ÙÀ̾Ë, ÆäÆ®¸® Á¢½Ã, Ŭ·ÎÀú ¹× ±âŸ Æ÷Àå ¼Ö·ç¼ÇÀ¸·Î ±¸ºÐµË´Ï´Ù. ÀÌ Áß º´°ú ¹ÙÀÌ¾Ë ºÐ¾ß´Â 2034³â±îÁö 40¾ï ´Þ·¯ÀÇ ¸ÅÃâÀÌ ¿¹»óµË´Ï´Ù. ÀÌ·¯ÇÑ ÆÐŰ¡ ¼Ö·ç¼ÇÀº IVD ºÐ¾ß¿¡¼­ ÇʼöÀûÀÌ¸ç ¿À¿°, ½À±â ¹× ºû¿¡ ´ëÇÑ Áß¿äÇÑ º¸È£¸¦ Á¦°øÇϰí Áø´Ü ½Ã¾à ¹× ½Ã·áÀÇ ¾ÈÁ¤¼º°ú Á¤È®¼ºÀ» À¯ÁöÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ±× ´Ù¿ëµµ´Â Ç÷¾×°ú ¼Òº¯ »ùÇÃÀÇ º¸°ü¿¡¼­ ºÐÀÚ ½Ã¾à ¹× »ýÈ­ÇÐ ½Ã¾à Æ÷Àå¿¡ À̸£±â±îÁö ´Ù¾çÇÑ ¿ëµµ·Î »ç¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ±¤¹üÀ§ÇÑ ¿ëµµ·Î º´ ¹× ¹ÙÀ̾ËÀº ü¿Ü Áø´Ü¿ë ÀǾàǰ(IVD) »ê¾÷¿¡¼­ ÇʼöÀûÀÎ Á¸Àç·Î ³²¾Æ ÀÖ½À´Ï´Ù.

½ÃÀå ¹üÀ§
½ÃÀÛ ¿¬µµ 2024³â
¿¹Ãø ¿¬µµ 2025-2034³â
½ÃÀÛ ±Ý¾× 86¾ï ´Þ·¯
¿¹Ãø ±Ý¾× 139¾ï ´Þ·¯
CAGR 5.1%

IVD Æ÷Àå ½ÃÀåÀº º´¿ø, ¿¬±¸¼Ò, Çмú ±â°ü µî ´Ù¾çÇÑ ÃÖÁ¾ »ç¿ëÀÚ ¼ö¿äµµ º¸°í ÀÖ½À´Ï´Ù. ÀÌ Áß Çмú±â°ü ºÎ¹®Àº 2025³âºÎÅÍ 2034³â±îÁö CAGR 7%·Î °¡Àå ±Þ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù. ÀÌ ¼ºÀåÀº Áø´Ü ±â¼úÀÇ ¿¬±¸ °³¹ß¿¡ ´ëÇÑ ÅõÀÚ°¡ Áõ°¡Çϰí Àֱ⠶§¹®ÀÔ´Ï´Ù. Çмú ±â°üÀº »õ·Î¿î Áø´Ü °Ë»ç, ½Ã¾à ¹× ±â¼ú °³¹ßÀ» Æ÷ÇÔÇÑ ÀÇÇÐ ¿¬±¸ÀÇ ÃßÁø¿¡ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ¿¬±¸ Ȱµ¿ÀÌ È®´ëµÊ¿¡ µû¶ó »ý¹°ÇÐÀû ½Ã·á¿Í ½Ã¾àÀÇ ¹«°á¼º°ú ¾ÈÁ¤¼ºÀ» À¯ÁöÇϴ Ư¼ö Æ÷Àå ¼Ö·ç¼ÇÀÇ Çʿ伺ÀÌ Ä¿Áö°í ÀÖ½À´Ï´Ù. ¿¬±¸°³¹ß ÅõÀÚÀÇ ±ÞÁõ°ú ¿¬±¸ ÁÖµµÇü ÀÌ´Ï¼ÅÆ¼ºêÀÇ È®´ë´Â Çмú ¸ñÀû¿¡ ¸Â´Â ¼±Áø ÆÐŰ¡ ¼Ö·ç¼Ç ¼ö¿ä¸¦ ´õ¿í °­È­ÇÒ °ÍÀÔ´Ï´Ù.

ºÏ¹Ì¿¡¼­´Â IVD Æ÷Àå ½ÃÀåÀÌ Å« Á¡À¯À²À» Â÷ÁöÇϰí ÀÖÀ¸¸ç, 2024³â¿¡´Â ½ÃÀå ÀüüÀÇ 35%¸¦ Â÷ÁöÇß½À´Ï´Ù. ÀÌ ¿ìÀ§¼ºÀº ÀÌ Áö¿ªÀÌ ÀÇ·á±â¼ú Çõ½Å¿¡¼­ ÁÖµµ±ÇÀ» Àâ°í ÀÖÀ¸¸ç, ƯÈ÷ Áø´Ü±â¼úÀÇ ¿¬±¸°³¹ß¿¡ ¸¹Àº ÅõÀÚ¸¦ Çϰí ÀÖ´Â °ÍÀÌ Å« ¿äÀÎÀÌ µÇ°í ÀÖ½À´Ï´Ù. ¸ÂÃãÇü ÀÇ·á ¹× Æ÷ÀÎÆ® ¿Àºê ÄÉ¾î °Ë»ç¿Í °°Àº °í±Þ Áø´Ü ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡´Â °í·ÉÈ­ »çȸ¿Í ÇÔ²² ½ÃÀå È®´ëÀÇ ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù. ÀÇ·á Á¦°øÀÚ¿Í ÀÇ·á±â°üÀÌ º¸´Ù È¿°úÀûÀ̰í È¿À²ÀûÀÎ Áø´Ü ¼Ö·ç¼ÇÀ» ¿ä±¸Çϰí ÀÖ´Â °¡¿îµ¥, ºÏ¹Ì¿¡¼­´Â °íǰÁúÀÇ Æ¯¼ö IVD Æ÷Àå¿¡ ´ëÇÑ ¿ä±¸°¡ °è¼ÓÇØ¼­ ÀÌ Áö¿ª ½ÃÀå ¼ºÀåÀÇ Áß¿äÇÑ ¿äÀÎÀÌ µÇ°í ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý ¹× Á¶»ç ¹üÀ§

  • ½ÃÀå ¹üÀ§ ¹× Á¤ÀÇ
  • ±âº» ÃßÁ¤ ¹× °è»ê
  • ¿¹Ãø °è»ê
  • µ¥ÀÌÅÍ ¼Ò½º
    • 1Â÷ µ¥ÀÌÅÍ
    • 2Â÷ µ¥ÀÌÅÍ
      • À¯·á Á¤º¸¿ø
      • °øÀû Á¤º¸¿ø

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ¾÷°è ÀλçÀÌÆ®

  • »ýÅÂ°è ºÐ¼®
    • ¹ë·ùüÀο¡ ¿µÇâÀ» ÁÖ´Â ¿äÀÎ
    • ÀÌÀÍ·ü ºÐ¼®
    • ÆÄ±«
    • Àå·¡ Àü¸Á
    • Á¦Á¶¾÷ü
    • À¯Åë¾÷ü
  • ÁÖ¿ä ´º½º ¹× ´ëó
  • ±ÔÁ¦ »óȲ
  • ¿µÇâ¿äÀÎ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • Áø´Ü °Ë»ç ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡
      • IVD Æ÷Àå ±â¼úÀÇ ¼±ÁøÈ­
      • ½ÅÈï ½ÃÀåÀÇ ÇコÄɾî È®´ë
      • ÇöÁö »ý»ê ¹× Æ÷Àå ¼ö¿ä
      • Áö¼Ó °¡´ÉÇÑ Æ÷Àå ¼Ö·ç¼Ç¿¡ ´ëÇÑ ÁÖ¸ñÀÇ Çâ»ó
    • ¾÷°èÀÇ ÀáÀçÀû À§Çè ¹× °úÁ¦
      • Ư¼ö Æ÷Àå ¼Ö·ç¼ÇÀÇ ³ôÀº ºñ¿ë
      • º¹ÀâÇÑ ±ÔÁ¦ ¿ä°Ç¿¡ ´ëÀÀ
  • ¼ºÀå °¡´É¼º ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®

Á¦4Àå °æÀï ±¸µµ

  • ¼­¹®
  • ±â¾÷ Á¡À¯À² ºÐ¼®
  • °æÀï Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º
  • Àü·« Àü¸Á ¸ÅÆ®¸¯½º

Á¦5Àå ½ÃÀå Ãß°è ¹× ¿¹Ãø : Á¦Ç°º°(2021-2034³â)

  • ÁÖ¿ä µ¿Çâ
  • º´ ¹× ¹ÙÀ̾Ë
  • Æ©ºê
  • ¼£·¹
  • Ŭ·ÎÀú
  • ±âŸ

Á¦6Àå ½ÃÀå Ãß°è ¹× ¿¹Ãø : ¿ëµµº°(2021-2034³â)

  • ÁÖ¿ä µ¿Çâ
  • ´ç´¢º´
  • °¨¿°Áõ
  • ¼øÈ¯±â Áúȯ
  • ÀÚ°¡¸é¿ª Áúȯ
  • Á¾¾çÇÐ
  • ¾à¹° °Ë»ç
  • ±âŸ

Á¦7Àå ½ÃÀå Ãß°è ¹× ¿¹Ãø : ÃÖÁ¾ ¿ëµµº°(2021-2034³â)

  • ÁÖ¿ä µ¿Çâ
  • º´¿ø
  • ¿¬±¸¼Ò
  • Çмú±â°ü
  • ±âŸ

Á¦8Àå ½ÃÀå Ãß°è ¹× ¿¹Ãø : Áö¿ªº°(2021-2034³â)

  • ÁÖ¿ä µ¿Çâ
  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
  • À¯·´
    • ¿µ±¹
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • ·¯½Ã¾Æ
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • Çѱ¹
    • È£ÁÖ
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • ³²¾ÆÇÁ¸®Ä«
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)

Á¦9Àå ±â¾÷ ÇÁ·ÎÆÄÀÏ

  • Abdos Labtech
  • Academy Medical Instruments
  • AdvaCare Pharma
  • Amcor
  • Amrit Scientific
  • Ajosha Bio Teknik
  • Aptargroup
  • Corning
  • Focus Technology
  • Fusion Biotech
  • Globe Scientific
  • Greiner Holding
  • Kindly Group
  • Labtech Disposables
  • Narang Medical
  • Oliver
  • Peacock Industries
  • VWR International
  • Yuhuan Kangjia
  • Zhuhai Ideal Biotech
AJY 25.04.11

The Global In-Vitro Diagnostics Packaging Market reached a valuation of USD 8.6 billion in 2024 and is estimated to grow at a CAGR of 5.1% from 2025 to 2034. The market's upward trajectory is driven by several factors. One of the primary drivers is the increasing demand for localized manufacturing and packaging solutions in emerging markets. These regions are seeing rapid advancements in healthcare infrastructure, resulting in an uptick in diagnostic tests and an urgent need for packaging solutions that ensure the integrity of these tests. As a result, more companies are focusing on packaging innovations that cater to the specific needs of these developing markets. The trend toward personalized medicine, point-of-care testing, and the growing aging population in developed regions further contribute to the demand for high-quality IVD packaging. This growth is further fueled by a greater focus on safety and precision in diagnostic testing.

In-Vitro Diagnostics Packaging Market - IMG1

In terms of product types, the market is segmented into tubes, bottles and vials, petri dishes, closures, and other packaging solutions. Of these, the bottles and vials segment is expected to generate USD 4 billion through 2034. These packaging solutions are essential in the IVD sector, providing crucial protection against contamination, moisture, and light, which helps preserve the stability and accuracy of diagnostic reagents and samples. Their versatility allows for a wide array of applications, from the storage of blood and urine samples to packaging molecular and biochemical reagents. This broad applicability continues to make bottles and vials indispensable in the IVD industry.

Market Scope
Start Year2024
Forecast Year2025-2034
Start Value$8.6 Billion
Forecast Value$13.9 Billion
CAGR5.1%

The IVD packaging market also sees demand from various end users, including hospitals, laboratories, academic institutions, and others. Among these, the academic institutions segment is projected to grow the fastest, with a CAGR of 7% between 2025 and 2034. This growth can be attributed to the increasing investments in research and development in diagnostic technologies. Academic institutions play a pivotal role in advancing medical research, including the development of new diagnostic tests, reagents, and techniques. As research activities expand, the need for specialized packaging solutions that maintain the integrity and stability of biological samples and reagents grows. The surge in R&D investments and the expansion of research-driven initiatives will only intensify the demand for advanced packaging solutions tailored for academic purposes.

In North America, the IVD packaging market holds a significant share, accounting for 35% of the total market in 2024. This dominance is largely driven by the region's leadership in medical technology innovation, with considerable investments in research and development, especially in diagnostic technologies. The rising demand for advanced diagnostic solutions, such as personalized medicine and point-of-care testing, coupled with the aging population, continues to fuel market expansion. As healthcare providers and institutions strive for more effective and efficient diagnostic solutions, the need for high-quality, specialized IVD packaging in North America remains a key factor in the region's market growth.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definitions
  • 1.2 Base estimates & calculations
  • 1.3 Forecast calculations
  • 1.4 Data sources
    • 1.4.1 Primary
    • 1.4.2 Secondary
      • 1.4.2.1 Paid sources
      • 1.4.2.2 Public sources

Chapter 2 Executive Summary

  • 2.1 Industry synopsis, 2022-2034

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
    • 3.1.1 Factor affecting the value chain
    • 3.1.2 Profit margin analysis
    • 3.1.3 Disruptions
    • 3.1.4 Future outlook
    • 3.1.5 Manufacturers
    • 3.1.6 Distributors
  • 3.2 Key news & initiatives
  • 3.3 Regulatory landscape
  • 3.4 Impact forces
    • 3.4.1 Growth drivers
      • 3.4.1.1 Rising demand for diagnostic test solutions
      • 3.4.1.2 Advancements in IVD packaging technologies
      • 3.4.1.3 Expansion of healthcare in emerging markets
      • 3.4.1.4 Demand for local manufacturing and packaging
      • 3.4.1.5 Increasing focus on sustainable packaging solutions
    • 3.4.2 Industry pitfalls & challenges
      • 3.4.2.1 High costs of specialized packaging solutions
      • 3.4.2.2 Navigating complex regulatory requirements
  • 3.5 Growth potential analysis
  • 3.6 Porter's analysis
  • 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Competitive positioning matrix
  • 4.4 Strategic outlook matrix

Chapter 5 Market Estimates & Forecast, By Product, 2021-2034 (USD Million & Kilo Tons)

  • 5.1 Key trends
  • 5.2 Bottles and vials
  • 5.3 Tubes
  • 5.4 Petri dishes
  • 5.5 Closures
  • 5.6 Others

Chapter 6 Market Estimates & Forecast, By Application, 2021-2034 (USD Million & Kilo Tons)

  • 6.1 Key trends
  • 6.2 Diabetes
  • 6.3 Infectious diseases
  • 6.4 Cardiology
  • 6.5 Autoimmune diseases
  • 6.6 Oncology
  • 6.7 Drug testing
  • 6.8 Others

Chapter 7 Market Estimates & Forecast, By End Use, 2021-2034 (USD Million & Kilo Tons)

  • 7.1 Key trends
  • 7.2 Hospitals
  • 7.3 Laboratories
  • 7.4 Academic institutes
  • 7.5 Others

Chapter 8 Market Estimates & Forecast, By Region, 2021-2034 (USD Million & Kilo Tons)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 UK
    • 8.3.2 Germany
    • 8.3.3 France
    • 8.3.4 Italy
    • 8.3.5 Spain
    • 8.3.6 Russia
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 India
    • 8.4.3 Japan
    • 8.4.4 South Korea
    • 8.4.5 Australia
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
  • 8.6 MEA
    • 8.6.1 South Africa
    • 8.6.2 Saudi Arabia
    • 8.6.3 UAE

Chapter 9 Company Profiles

  • 9.1 Abdos Labtech
  • 9.2 Academy Medical Instruments
  • 9.3 AdvaCare Pharma
  • 9.4 Amcor
  • 9.5 Amrit Scientific
  • 9.6 Ajosha Bio Teknik
  • 9.7 Aptargroup
  • 9.8 Corning
  • 9.9 Focus Technology
  • 9.10 Fusion Biotech
  • 9.11 Globe Scientific
  • 9.12 Greiner Holding
  • 9.13 Kindly Group
  • 9.14 Labtech Disposables
  • 9.15 Narang Medical
  • 9.16 Oliver
  • 9.17 Peacock Industries
  • 9.18 VWR International
  • 9.19 Yuhuan Kangjia
  • 9.20 Zhuhai Ideal Biotech
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦